Peer-influenced content. Sources you trust. No registration required. This is HCN.
Guideline Central
Research presented at the APA 2024 Annual Meeting sheds light on innovative treatments and the multifaceted burden of anxiety disorders, highlighting significant advances in managing GAD and related comorbidities.
Psychiatry May 21st 2024
Psych Congress Network
Lithium continues to be recognized as the most reliable mood stabilizer for bipolar disorder patients with a history of mania, necessitating precise management of dosages to prevent significant side effects.
Psychiatry May 7th 2024
Healthline
Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.
Endocrinology, Diabetes, Metabolism April 30th 2024
Psychiatrist.com
Lamotrigine stands out for its efficacy in preventing depressive episodes in bipolar I disorder, offering a nuanced option for mood stabilization with an antidepressant emphasis. Understanding its specific clinical applications can enhance treatment strategies for mood disorders.
Clinical Pharmacology February 13th 2024
ReachMD
Discover how prucalopride, typically used as a laxative, is showing promise as a cognitive enhancer in recent neurological research. Learn more about its potential implications for treating cognitive deficits in mood disorders.
Neurology July 5th 2023